Sha Mi
34Patents
12h-index
40Co-inventors
81Inventor score
Filing activity: Jul 18, 1996 → Aug 16, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6043344A | Human CTLA-8 and uses of CTLA-8-related proteins | Emerging Cross-Sectional Technologies | 70 | Expired |
| US8058406B2 | Composition comprising antibodies to LINGO or fragments thereof | Chemistry; Metallurgy | 37 | Active |
| US8551476B2 | SP35 antibodies and uses thereof | Chemistry; Metallurgy | 33 | Active |
| US8425910B2 | Composition comprising antibodies to LINGO or fragments thereof | Chemistry; Metallurgy | 32 | Active |
| US9066984B2 | Sp35 antibodies and uses thereof | Chemistry; Metallurgy | 26 | Active |
| US8642040B2 | Methods for promoting myelination, neuronal survival and oligodendrocyte differentiation via administration of Sp35 or TrkA antagonists | Chemistry; Metallurgy | 23 | Active |
| US6902735B1 | Antibodies to human IL-17F and other CTLA-8-related proteins | Human Necessities | 23 | Expired |
| US9107884B2 | Use of semaphorin 6A for promoting myelination and oligodendrocyte differentiation | Chemistry; Metallurgy | 16 | Active |
| US8128926B2 | Sp35 antibodies and uses thereof | Chemistry; Metallurgy | 16 | Active |
| US6074849A | Polynucleotides encoding human CTLA-8 related proteins | Emerging Cross-Sectional Technologies | 13 | Expired |
| US7785829B2 | Nogo receptor binding protein | Chemistry; Metallurgy | 12 | Expired |
| US8153580B2 | Nogo receptor binding protein | Chemistry; Metallurgy | 12 | Active |
| US7846438B2 | Methods of promoting neurite outgrowth with soluble TAJ polypeptides | Physics | 7 | Active |
| US9550798B2 | Compounds that are S1P modulating agents and/or ATX modulating agents | Chemistry; Metallurgy | 7 | Active |
| US8765662B2 | NOGO receptor binding protein | Chemistry; Metallurgy | 6 | Active |
| US8486893B2 | Treatment of conditions involving demyelination | Chemistry; Metallurgy | 6 | Expired |
| US8501178B2 | Use of DR6 and p75 antagonists to promote survival of cells of the nervous system | Chemistry; Metallurgy | 6 | Active |
| US8609407B2 | Sp35 antibodies and uses thereof | Chemistry; Metallurgy | 6 | Active |
| US9522889B2 | ATX modulating agents | Emerging Cross-Sectional Technologies | 5 | Active |
| US8894999B2 | Use of DR6 and p75 antagonists to promote survival of cells of the nervous system | Chemistry; Metallurgy | 5 | Active |
| US9340527B2 | S1P modulating agents | Chemistry; Metallurgy | 4 | Active |
| US6312921A | Secreted proteins and polynucleotides encoding them | Human Necessities | 4 | Expired |
| US9555050B2 | ATX modulating agents | Chemistry; Metallurgy | 4 | Active |
| US8932821B2 | NOGO receptor binding protein | Chemistry; Metallurgy | 3 | Active |
| US9808449B2 | S1P modulating agents | Chemistry; Metallurgy | 2 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.